1. Home
  2. KEYS vs ONC Comparison

KEYS vs ONC Comparison

Compare KEYS & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEYS
  • ONC
  • Stock Information
  • Founded
  • KEYS 1939
  • ONC 2010
  • Country
  • KEYS United States
  • ONC Switzerland
  • Employees
  • KEYS N/A
  • ONC N/A
  • Industry
  • KEYS Industrial Machinery/Components
  • ONC Biotechnology: Pharmaceutical Preparations
  • Sector
  • KEYS Industrials
  • ONC Health Care
  • Exchange
  • KEYS Nasdaq
  • ONC Nasdaq
  • Market Cap
  • KEYS 29.8B
  • ONC 34.8B
  • IPO Year
  • KEYS N/A
  • ONC N/A
  • Fundamental
  • Price
  • KEYS $195.45
  • ONC $335.60
  • Analyst Decision
  • KEYS Buy
  • ONC Strong Buy
  • Analyst Count
  • KEYS 10
  • ONC 12
  • Target Price
  • KEYS $212.60
  • ONC $369.50
  • AVG Volume (30 Days)
  • KEYS 1.5M
  • ONC 312.3K
  • Earning Date
  • KEYS 11-24-2025
  • ONC 11-06-2025
  • Dividend Yield
  • KEYS N/A
  • ONC N/A
  • EPS Growth
  • KEYS 39.23
  • ONC N/A
  • EPS
  • KEYS 4.89
  • ONC 0.29
  • Revenue
  • KEYS $5,375,000,000.00
  • ONC $4,998,489,124.00
  • Revenue This Year
  • KEYS $7.74
  • ONC $35.34
  • Revenue Next Year
  • KEYS $6.30
  • ONC $22.45
  • P/E Ratio
  • KEYS $40.00
  • ONC $1,138.71
  • Revenue Growth
  • KEYS 7.95
  • ONC 53.47
  • 52 Week Low
  • KEYS $121.43
  • ONC $170.99
  • 52 Week High
  • KEYS $201.50
  • ONC $385.22
  • Technical
  • Relative Strength Index (RSI)
  • KEYS 67.30
  • ONC 48.44
  • Support Level
  • KEYS $167.23
  • ONC $322.41
  • Resistance Level
  • KEYS $179.57
  • ONC $356.55
  • Average True Range (ATR)
  • KEYS 5.99
  • ONC 16.26
  • MACD
  • KEYS 0.34
  • ONC -1.72
  • Stochastic Oscillator
  • KEYS 82.35
  • ONC 32.03

About KEYS Keysight Technologies Inc.

Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Share on Social Networks: